EnoxaparinsodiumACTSinmuchthesamewayasLMWH,butitshouldbenotedthattheefficacyofvariousLMWHisdifferent.Currently,multi-centertrialsonlyconfirmthatenoxaparinismoreeffectivethanordinaryheparininthetreatme
AndvitaminK,anti-plateletaggregationdrugs,non-steroidalanti-inflammatorydrugsanddextran,etc.Combinationuseofthefollowingdrugsisnotrecommended(combinedusemayincreasebleedingtendency):Acetylsalicylicaci
1.1mg/kg,twiceaday.Iv:loadingdoseof30mgcanbegivenintravenouslywhennecessary.2.Arterialinjection:inject1mg/kgofbodyweightintothearterialcathetertopreventextracorporealcirculationcoagulation.Ifthepatien
1.Enoxaparinsodiummaycausethrombocytopenia,occasionallyabnormalaminotransferaseandalkalinephosphatase,rarelylocalecchymosisandabnormalliverfunctionafterinjection.2.Intrathecalepiduralanesthesiaorposto